- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
Board of Governors selects UF to lead medical marijuana research consortium
As the lead institution, UF will receive $1.5 million in annual recurrent funding from the state of Florida to support the research mission of the Consortium for Medical Marijuana Clinical Outcomes Research.
NIH grant will fund study of telehealth for adolescents and young adults with asthma
UF College of Pharmacy researchers will investigate whether telehealth will improve asthma medication adherence and health outcomes.
Popular quinolone ear drops carry risk of eardrum perforation
A new study by University of Florida Health researchers shows quinolone ear drops might cause a perforated eardrum, which can lead to hearing loss.
UF looks forward to meeting alumni and friends at the upcoming ISPOR meeting
The International Society for Pharmacoeconomics and Outcomes Research will take place May 18-22 in New Orleans.
Dawwas and Jiang awarded inaugural POP graduate student awards
Ghadeer Dawwas, Ph.D., received the “POP Graduate Student Publication Award” and Xinyi “Rose” Jiang, M.S. was honored with the “Leadership Service Award.”
Congratulations Class of 2019 Graduates
Participating in the spring Ph.D. commencement ceremony were Wei Wang, Yan Li and Juan Hincapie-Castillo. Also graduating were M.S. students: Ching-Yu (Jessie) Wang and Fatimah Alyami.
Welcome to the Department of Pharmaceutical Outcomes and Policy
Thank you for your interest in our department, and our outstanding faculty, students and staff who represent our broad range of programs and resources. Faculty are actively engaged in the entry-level Pharm.D. program and our own graduate program, including one of the nation’s largest Ph.D. programs in pharmaceutical outcomes and policy, a research-focused residential M.S. program and an applied online M.S. program geared toward working professionals.
The department’s focus in research and graduate training is centered on the evaluation of drugs and related medical technology. This focus includes classic pharmacoepidemiologic and pharmacoeconomic work, as well as pharmaceutical health services research with a focus on quality and policy involving medication use. Our program has grown tremendously over the past five years with more to come. To find out more, please refer to our annual report and reach out or visit us in beautiful Florida to see one of the nation’s top 10 universities and top 10 pharmacy colleges.
Almut G. Winterstein, Ph.D.
Department Chair
2018 Annual Report
Events
POP Seminar Announcement: Motomori Lewis
Motomori Lewis is a first year PhD student who joined the POP program in Fall 2018. Motomori received her Bachelors in Public Health and Bachelors in Biomedical Sciences from the […]
POP Seminar Announcement: Xi Wang
Xi Wang received her bachelor’s degree from Xiangya School of Medicine, Central South University, China and her Master of Public Health in epidemiology from Emory University. Xi’s desires to become […]